Vascular Graft Market Report Provide Recent Developments and Strategies Which Focuses on Industry Situation Along With Future Scenario

The market for vascular grafts is expected to reach $ 6,218 million in 2023, growing at an average annual rate of 5.7% from 2017 to 2023.

Vascular grafting is a medical device used in surgical procedures to convert blood flow from one area to another through vascular reconnection. Vascular grafting is performed in patients with clogged arteries to restore normal blood flow in the body. Increased incidence of lifestyle-related diseases has increased demand for vascular grafts.

The global market for vascular grafting is caused by increased risk factors for vascular disorders, hyperglycemia, hypertension, and vascular occlusion. In addition, a sedentary lifestyle, increased elderly population and technological advancement are expected to complement market growth during the forecast period. However, the increased cost of treatment and complications associated with prosthetic transplants impede market growth. Conversely, rising awareness of vascular grafts and emerging market opportunities in emerging Asia Pacific and LAMEA regions are expected to provide opportunities for key market participants during the forecast period.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2435?utm_source=sy

The list of key players profiled in this report include
• B. Braun Melsungen AG
• C. R. Bard Inc.
• Cardinal Health Inc.
• Cook Medical Inc.
• Endologix Inc.
• LeMaitre Vascular Inc.
• MAQUET Holding B.V. & Co. KG
• Medtronic plc
• Terumo Corporation
• W. L. Gore & Associates Inc.
 
Other key players in the value chain include Cardiatis S.A., Jotec GmbH, Lombard Medical, Inc., and Nano Endoluminal.


The endovascular aneurysm repair stent grafts segment is expected to maintain its dominant position during the forecast period, owing to the associated benefits of being a minimally invasive procedure as compared to open-chest or open-abdominal aneurysm surgery. This has boosted endovascular aneurysm repair stent grafts market, as the total time required for the surgery is reduced by several days.

The biosynthetic raw material segment is expected to grow at a CAGR of 6.5% during the forecast period, owing to the combination of properties of both synthetic as well as biological materials, which give optimal results.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/2435?utm_source=sy

Key Findings of the Vascular Grafts Market:
• The polytetrafluoroethylene (PTFE) segment accounted for more than half of the raw materials market share in 2016.
• The endovascular aneurysm repair stent grafts segment accounted for nearly three-fifths share of the global market in 2016, and is expected to grow at a CAGR of 6.2% from 2017 to 2023.
• The hospitals segment accounted for more than half of the end users share in 2016.
• Asia-Pacific is expected to grow at the highest CAGR of 7.5% from 2017 to 2023.

North America accounted for a major share (more than half) in the global market in 2016, and is expected to maintain its dominance throughout the forecast period, owing to the increase in incidence of vascular disorders & renal diseases and rise in patient awareness about the benefits of vascular graft surgery. In addition, high adoption rate of technologically advanced devices and presence of highly sophisticated healthcare infrastructures are expected to offer new growth opportunities to the players in the market.

Access Full Summery @ https://www.alliedmarketresearch.com/vascular-graft-market?utm_source=sy

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.